UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...

The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Development of a stem cell therapy for sickle cell disease from Vertex and development partner CRISPR therapeutics can go ahead, after the FDA lifted a hold on a review. The companies had applied ...

CRISPR Therapeutics ($CRSP) has endured a tough year since gaining several important regulatory approvals for its ...

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...

CRISPR gene editing is widely regarded as one of the most important leaps in biomedical and agricultural research, with ...

How evolution evolved: the risks and rewards of gene-editing technology - India Block speaks to paediatrician and TV writer ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...